NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3025% below fair value
$15.29+0.04 (+0.26%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
NeoGenomics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NeoGenomics's revenue for the twelve months ending Sep 30, 2026 was $787.75M, up 11.1% year over year. For fiscal 2025 it was $727.33M, up 10.1% from the year before. Over ten years it grew 22.0% a year on average. The highest annual figure on record is $727.33M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $727.33M | +10.1% |
| FY2024 | Dec 31, 2024 | $660.57M | +11.6% |
| FY2023 | Dec 31, 2023 | $591.64M | +16.1% |
| FY2022 | Dec 31, 2022 | $509.73M | +5.2% |
| FY2021 | Dec 31, 2021 | $484.33M | +9.0% |
| FY2020 | Dec 31, 2020 | $444.45M | +8.7% |
| FY2019 | Dec 31, 2019 | $408.83M | +47.7% |
| FY2018 | Dec 31, 2018 | $276.74M | +15.2% |
| FY2017 | Dec 31, 2017 | $240.25M | +3.6% |
| FY2016 | Dec 31, 2016 | $231.81M | +132.3% |
| FY2015 | Dec 31, 2015 | $99.80M | +14.6% |
| FY2014 | Dec 31, 2014 | $87.07M | +31.0% |
| FY2013 | Dec 31, 2013 | $66.47M | +11.0% |
| FY2012 | Dec 31, 2012 | $59.87M | +37.7% |
| FY2011 | Dec 31, 2011 | $43.48M | +26.5% |
| FY2010 | Dec 31, 2010 | $34.37M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $209.25M | +11.4% |
| Q2 FY2026 | Jun 30, 2026 | $201.66M | +11.2% |
| Q1 FY2026 | Mar 31, 2026 | $186.67M | +11.1% |
| Q4 FY2025 | Dec 31, 2025 | $190.17M | +10.6% |
| Q3 FY2025 | Sep 30, 2025 | $187.80M | +11.9% |
| Q2 FY2025 | Jun 30, 2025 | $181.33M | +10.2% |
| Q1 FY2025 | Mar 31, 2025 | $168.04M | +7.5% |
| Q4 FY2024 | Dec 31, 2024 | $172.00M | +10.6% |
| Q3 FY2024 | Sep 30, 2024 | $167.82M | +10.4% |
| Q2 FY2024 | Jun 30, 2024 | $164.50M | +12.0% |
| Q1 FY2024 | Mar 31, 2024 | $156.24M | +13.9% |
| Q4 FY2023 | Dec 31, 2023 | $155.55M | +12.1% |
| Q3 FY2023 | Sep 30, 2023 | $151.95M | +18.0% |
| Q2 FY2023 | Jun 30, 2023 | $146.92M | +17.5% |
| Q1 FY2023 | Mar 31, 2023 | $137.22M | +17.1% |
| Q4 FY2022 | Dec 31, 2022 | $138.71M | +10.3% |
| Q3 FY2022 | Sep 30, 2022 | $128.78M | +6.1% |
| Q2 FY2022 | Jun 30, 2022 | $125.07M | +2.8% |
| Q1 FY2022 | Mar 31, 2022 | $117.17M | +1.4% |
| Q4 FY2021 | Dec 31, 2021 | $125.73M | -0.2% |
| Q3 FY2021 | Sep 30, 2021 | $121.34M | -3.3% |
| Q2 FY2021 | Jun 30, 2021 | $121.72M | +39.9% |
| Q1 FY2021 | Mar 31, 2021 | $115.53M | +9.0% |
| Q4 FY2020 | Dec 31, 2020 | $126.00M | +17.9% |
| Q3 FY2020 | Sep 30, 2020 | $125.44M | +19.8% |
| Q2 FY2020 | Jun 30, 2020 | $86.98M | -14.5% |
| Q1 FY2020 | Mar 31, 2020 | $106.03M | +10.9% |
| Q4 FY2019 | Dec 31, 2019 | $106.87M | +39.7% |
| Q3 FY2019 | Sep 30, 2019 | $104.67M | +51.5% |
| Q2 FY2019 | Jun 30, 2019 | $101.71M | +50.1% |
| Q1 FY2019 | Mar 31, 2019 | $95.58M | +50.7% |
| Q4 FY2018 | Dec 31, 2018 | $76.48M | +24.5% |
| Q3 FY2018 | Sep 30, 2018 | $69.10M | +16.8% |
| Q2 FY2018 | Jun 30, 2018 | $67.75M | +8.8% |
| Q1 FY2018 | Mar 31, 2018 | $63.42M | +10.4% |
| Q4 FY2017 | Dec 31, 2017 | $61.42M | +1.5% |
| Q3 FY2017 | Sep 30, 2017 | $59.14M | – |
| Q2 FY2017 | Jun 30, 2017 | $62.26M | – |
| Q1 FY2017 | Mar 31, 2017 | $57.43M | – |
| Q4 FY2016 | Dec 31, 2016 | $60.49M | – |
See a number that looks wrong?